Project NICCI - ML29328

Basic data

Title:
NICCI - ML29328
Duration:
01/04/2017 to 31/12/2020
Abstract / short description:
A PHASE II, SINGLE-ARMED, MULTICENTER TRIAL OF NEOADJUVANT VISMODEGIB IN PATIENTS WITH LARGE AND/OR RECURRENT RESECTABLE BASAL CELL CARCINOMA
– NICCI -
A trial of the Arbeitsgemeinschaft Dermatologische Onkologie (ADO)

Involved staff

Managers

Faculty of Medicine
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Gießen, Hessen, Germany
Help

will be deleted permanently. This cannot be undone.